What this ETF is trying to do

The Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund that focuses on the pharmaceutical industry. This means it invests in companies that create medicines and healthcare products.

What the numbers show

As of October 7, 2026, the current price of one share is $121.53. An estimated price from roughly one year ago was about $95.11.

When looking at how this ETF has performed, it is important to understand two different measurements:

• Price Return: This measures only the change in the share price. For example, the one-year price return was approximately 27.78%. The year-to-date (YTD) price return is about 16.25%.

• Total Return: This reflects the overall return, including both the share price movement and any cash distributions paid out. The one-year total return was approximately 29.09%, and the YTD total return is about 17.17%.

Over a three-year period, the price return was approximately 69.14%, while the total return was approximately 74.55%.

Income and distribution explanation

This ETF pays out cash to investors through distributions. The distribution yield is approximately 0.93%. In the last year, the trailing distributions were $1.13 per share. These payments usually happen every quarter (four times a year). It is important to remember that a distribution yield is not the same as total return.

NAV erosion explanation

Some investors watch for "NAV erosion." This refers to a situation where the value of the underlying assets in the fund drops significantly. For this ETF, the erosion-risk score is 100, and the label states "No price erosion detected." There is no severe erosion-risk flag for this fund.

Pros

• Strong Growth: The ETF has shown significant price and total returns over the last one and three years.

• Stability: No price erosion was detected by StockValueFinder's measurements.

• Top Holdings: The portfolio includes large companies such as Amgen Inc (5.68%), Abbott Laboratories (5.65%), and Merck & Co Inc (5.48%).

Cons

• Lower Yield: The distribution yield is relatively low at approximately 0.93%.

• Partial Data: The list of holdings provided only shows the largest companies; it is not a complete list of everything the ETF owns. Note that holdings can change over time.

Beginner takeaway

The PJP ETF tracks companies in the medicine industry. It has experienced significant share-price growth over the last few years and provides small, regular cash distributions to investors.